Regulatory Writing Deadlines: The Pressure to Get It Right the First Time

Kamiya Crabtree
A woman writes notes at her desk.

Anyone who’s worked in the medical device industry knows that regulatory deadlines aren’t just part of the process—they define it.

Whether you’re drafting a Clinical Evaluation Report (CER) or preparing an IVDR or MDR submission, there’s one golden rule everyone learns quickly: you feel the pressure to get it right the first time, because in this field, second chances are rare—and costly.

And that pressure? It doesn’t just come from the clock. It comes from the complexity of the content, the coordination required across teams, and the ever-present reality that regulators aren’t grading on a curve.

Why the Clock Is Always Ticking and Coordinating Moving Pieces

In regulatory writing, time is always a pressure point. While the device may be ready, the trial complete, and the data in hand, without well-aligned and structured documentation, the product can’t move forward. Writing typically happens late in the development cycle, and the responsibility to wrap it up quickly falls squarely on the regulatory team.

Revisions might be allowed, but delays can have significant consequences, pushing back launch dates, sales forecasts, and patient access. In a competitive market, even a few weeks’ delay can make a huge impact.

In other words, the sooner it’s done, the sooner it’s in the hands of the people who need it.

Take the Clinical Evaluation Report (CER), for example. It requires input from clinical, risk, and quality teams, each working on different timelines. If one team is delayed or key data is missing, the regulatory writer is left to fill in the gaps. Yet the final document still needs to be clear, compliant, and scientifically sound. Managing these moving parts under intense time pressure is where the real challenge lies.

And despite all this, the report must be coherent. It must make sense to regulators, and it must do so in language that’s both technically precise and easy to follow. Balancing scientific depth with regulatory clarity, while coordinating teams and racing deadlines, is what makes regulatory writing uniquely demanding.

Time Pressure + Technical Complexity = A Tough Combo

Regulatory writing is anything but straightforward. It’s high-pressure work that requires interpreting complex data, aligning with evolving guidelines, and managing competing timelines. You’re expected to translate clinical, safety, or performance data into documents that meet both internal and regulatory expectations.

Timelines are rarely in your favour, and last-minute data, shifting guidance, and delayed inputs from other teams are common. Yet, the final document still has to be accurate and on time.

Under pressure, shortcuts can be tempting: citing claims without solid evidence, glossing over exclusions, or relying on unchecked references. These might seem small, but regulators spot them instantly. One inconsistency can spark a chain of questions, delaying approval. The internal cost involves pulling teams back into work they thought was finished, creating stress and draining resources.

How To Manage the Pressure

While the pressure may never disappear entirely, you can develop strategies to manage it effectively and deliver strong submissions consistently. Here’s how:

1. Build Time Buffers Wherever Possible (and Stick to Them)

Time buffers aren’t just a luxury, they’re a necessity as things will go wrong. A key staff member will be on leave, a literature search might surface late-breaking studies, or a formatting requirement will change mid-review. Planning for the unexpected is what keeps your timeline intact.

How to do it:

  • Create internal deadlines at least 3–5 working days before submission.
  • Schedule a formal buffer period at the end of the review cycle for last-minute fixes, formatting, or unanticipated input.
  • Use a Gantt chart or timeline visual to map dependencies and highlight bottlenecks early.

Tip: Treat internal deadlines like external ones. Lock them in calendars, send reminders, and keep them visible in team trackers so they’re taken just as seriously.

2. Use Templates and Checklists to Reduce Cognitive Load

Regulatory writing isn’t just about words, it’s about structure, traceability, and completeness. Using well-maintained templates, guides, and submission checklists allows writers to focus on content rather than reformatting or double-checking document layout.

Best practices:

  • Maintain validated templates for CERs, PMS Plans, SSCPs, and more.
  • Create a library of pre-approved justifications, definitions, and citations.
  • Use trackers or collaborative SharePoint folders to keep everything in one place.

Tip: Maintain a document library with pre-approved phrasing for recurring justifications, definitions, and regulatory language to speed up writing and ensure consistency.

3. Clarify the “Why” Behind Every Section

When working fast, it’s easy to fall into the trap of filling sections with text that sounds right but lacks substance. Writers who stay close to the underlying intent of each section, whether it’s explaining benefit-risk, post-market follow-up, or equivalence, are better positioned to write persuasively and pass regulatory scrutiny.

Tip: Before writing each section, note down the question you’re answering. For example: “What is the clinical benefit of this device, and how is it supported by evidence?” Then answer that clearly and directly.

4. Align Stakeholders Early

Regulatory writing relies on input from clinical, risk, and quality teams. When these inputs arrive late or out of sync, the whole writing timeline suffers.

How to improve:

  • Hold a project kick-off call to align timelines and expectations across teams.
  • Share a high-level plan with key stakeholders early, especially if input will be staggered.
  • Confirm who’s reviewing what, and when, to avoid overlaps or gaps.

Example: For an MDR CER, a short cross-functional alignment meeting early in the project avoided weeks of back-and-forth during the review phase.

5. Break Big Tasks into Smaller Wins

Large documents like CERs or SSCPs, and especially full Technical Files can feel overwhelming. Breaking the work into logical sections and setting mini-deadlines helps manage workload and keep momentum.

What works:

  • Set internal milestones for key sections (e.g. clinical data, Annex II documents, risk-benefit).
  • Track progress visibly so the team stays motivated and aligned.
  • Divide the document by section (e.g. clinical background, state of the art, risk-benefit analysis, PMS summary) and assign clear ownership where possible.

Tip: Celebrate section sign-offs as mini-successes—they build confidence and maintain pace. Also, create a visual dashboard (even a basic traffic-light tracker in Excel) to show section status, e.g., red for in progress, amber for under review, green for approved. It helps everyone see at a glance where things stand and what needs focus next.

Bonus benefit: Smaller chunks are also easier to quality check, making it more likely that errors or inconsistencies are spotted early—before they snowball into regulatory queries.

6. Learn from Every Submission

Every regulatory submission, whether smooth, delayed, or somewhere in between, is packed with lessons. The key is capturing those insights while they’re still fresh and feeding them back into future projects. That’s how teams evolve from “just getting it done” to building consistently efficient, high-quality submissions.

How to do it:

  • Hold post-submission meetings: Within a week or two of submitting, schedule a short debrief session. Ask: What went well? What slowed us down? What could we do differently next time?
  • Involve everyone: Writers, project managers, and any contributors should have a voice. Often, the people managing literature, quality checks, or stakeholder feedback have the best insights into where time was lost, or saved.
  • Document and apply learnings: Keep a running log of tips, regulatory feedback, time-saving methods, and submission pitfalls.

Conclusion: High Pressure, High Standards—Manageable with the Right Tools

There’s no denying that writing regulatory documents under tight deadlines can be intense. The expectations are high, the work is technical, and the timelines are often compressed. But by planning strategically, working collaboratively, and using the right tools and frameworks, you can consistently produce documents that meet both internal expectations and regulatory requirements.

The key is not to chase perfection, but to build processes that support quality from the very start. Because getting it right the first time might not always be possible, but it should always be the goal.

When everything comes together, when the data aligns, the document flows, and the submission is accepted without question, there’s a distinct sense of pride that accompanies the moment.

Whether you’re preparing a technical file, responding to questions from a notified body, or working toward approval, our team provides practical, tailored support at every stage. We offer strategic guidance across regulatory frameworks, assist with technical documentation, and help you stay aligned with evolving requirements.

If you’re looking for a trusted partner to take the pressure out of compliance, get in touch with Mantra Systems today.

Related articles

  1. Medical phone software being used to communicate with a monitor placed on a mans skin.

    IEC 62366-1:2015 Demystified – Essential Usability Testing for Medical Devices

    What should be included in a Usability Engineering File? What steps do you need to take to ensure compliance and meet standards?

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  2. Video poster frame for Episode 2 of our ongoing series.

    Clinical Evaluation Masterclass: Appraisal of literature sources has not been conducted properly - Episode 2

    Our ongoing series covers one of the most frequent reasons for CER rejection: a poor appraisal of literature sources.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  3. A lone figure navigates a rocky coastline.

    Navigating CAPA Terminology: Key Terms for Medical Device Professionals

    We define and explain the language required to work within a Quality Management System (QMS).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  4. Video poster frame for Episode 1 of our new series.

    Clinical Evaluation Masterclass: Overcoming Non-conformities - Episode 1

    In this series, we work step-by-step through common Non-Conformities to ensure you are always ahead of possible challenges on the way to MDR approval.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  5. A man carefully steps across a cliff-face. An analogy for assessing risk.

    Top 5 Common Pitfalls to Avoid During Risk Assessment

    Learn how to sidestep costly mistakes which manufacturers commonly make. From hazard ID to post-market surveillance, we help you improve safety and speed up approvals.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  6. A label maker printing bar-code labels.

    Labelling 101: A Comprehensive Overview for Medical Device Manufacturers

    Labelling and packaging are critical elements to ensuring safety, compliance, and ease of use.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  7. An illustration of a brain-shaped object on an abstract background.

    European Commission Guidelines on Prohibited Artificial Intelligence Practices

    Summary of the 8 AI practices prohibited by the EU 2024/1689 artificial intelligence (AI) Act.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  8. A compass being used to navigate across mountainous countryside.

    Navigating Non-Conformities in Technical Documentation

    We explore how to manage non-conformities effectively and implement Corrective and Preventive Actions (CAPAs).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  9. A photograph of a literal maze that we're using as a clever metaphor.

    Mastering the EU MDR: Essential Steps for Compliance-Ready Docs

    If you're uncertain about the readiness of your EU MDR documentation, this article provides an overview of the essential steps to ensure you’re on track.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  10. An illustration showing scientists at work.

    A Guide to Electronic Instructions for Use (eIFU)

    Electronic Instructions for Use (eIFUs) are set to revolutionise how medical device instructions are delivered. We explore what this means for you.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  11. Two helicopters look as if they are about to collide: An analogy for risk.

    Navigating Risk Management Requirements under the EU MDR

    This is a cornerstone of EU MDR 2017/745, requiring a continuous, well-documented approach. We unpack key requirements and provide actionable strategies.

    Peter Boxall Peter Boxall Lead Medical Writer
  12. A doctor operates a tablet computer.

    Beyond the Acronyms: Understanding SaMD and SiMD

    As software advancements continue, the line between traditional hardware-centric medical devices and software-driven solutions becomes increasingly blurred.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  13. A team of profesional-looking people sit around a table, congratulating themselves.

    Extending the Validity of your IVDD Certificates – Key Dates

    The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. We explain what this means for manufacturers.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  14. A team of profesional-looking people sit around a table, congratulating themselves.

    GSPR 1: A New Era of Performance with Safety at the Core

    This regulation emphasizes risk management, durable design & biocompatibility to ensure medical devices are safe and effective. GSPR 1 protects users while driving innovation in medical technology.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  15. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  16. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  17. A hospital room full of equipment with futuristic user interfaces.

    IMDRF Sets the Standard: 10 Key Principles for AI-enabled Medical Devices

    Good Machine Learning Practice (GMLP) principles ensure safe devices, covering intended use, clinical evaluation & Human-AI Interaction (HAII).

    Ron Sangal Ron Sangal Lead Medical Writer
  18. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  19. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  20. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  21. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  22. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  23. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  24. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  25. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  26. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  27. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  28. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  29. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  30. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  31. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  32. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  33. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  34. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  35. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  36. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  37. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  38. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  39. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  40. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  41. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  42. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  43. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  44. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  45. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  46. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  47. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  48. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  49. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  50. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  51. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  52. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today